Physician profile
Michael Wong
NPI 1538322870
$30,831.55
in general payments reported to CMS, 2019-2025
60 companies · $2,977 in 2025
The $2,977 reported for 2025 was more than what 85% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,631 · 2020: $3,049 · 2021: $4,115 · 2022: $4,077 · 2023: $6,214 · 2024: $2,768 · 2025: $2,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,501 · Travel and Lodging: $3,458.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,501.32 |
| Travel and Lodging | $3,457.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $8,559.85 | 2019-2021 | |
| Abbott Laboratories | $3,698.37 | 2019-2025 | Proclaim, Octrode, Eterna |
| Saluda Medical Americas, INC. | $2,634.39 | 2023-2025 | Evoke Scs, Evoke |
| Mml US, INC. | $2,583.12 | 2022-2025 | Reactiv8 |
| Nevro Corp. | $1,464.20 | 2019-2024 | Senza |
| Boston Scientific Corporation | $1,368.01 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Spinal Simplicity, LLC | $1,214.08 | 2022-2025 | Ha Minuteman G3-R |
| Collegium Pharmaceutical, INC. | $844.00 | 2019-2025 | Xtampza, Belbuca |
| Vertos Medical, INC. | $804.57 | 2019-2024 | Mild Device Kit |
| Abbvie INC. | $618.45 | 2021-2025 | Ubrelvy, Qulipta |
| Electronic Waveform Lab, INC. | $414.20 | 2019-2023 | |
| Pfizer INC. | $391.03 | 2019-2023 | |
| Amgen INC. | $382.80 | 2019-2022 | |
| Grt US Holding, INC. | $381.72 | 2020-2022 | |
| Allergan, INC. | $361.88 | 2020-2022 |
Show all 60 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.